• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-SARS-COV2 TOTAL REAGENT PACK; IN VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-SARS-COV2 TOTAL REAGENT PACK; IN VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6199922
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/25/2021
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that a false reactive vitros cov2tot result was obtained when a level 1 cov2tot qc fluid was processed using vitros cov2tot reagent lot 0380 on a vitros eci immunodiagnostic system.A definitive cause of the event was not established.The event occurred as part of an internal vitros cov2tot lot 0100 qc post-expiry stability test event.A possible cause of the issue is the cov2tot lot 0100 qc fluid which had expired prior to testing.However, additional cov2tot results obtained during the same post-expiry qc fluid test event were acceptable.A vitros cov2tot reagent lot 0380 reagent issue is an unlikely contributor to the event, as the remaining results from vitros cov2tot lot 0100 qc fluid testing were acceptable.Additionally, ongoing tracking and trending of complaints has not identified any signals that would point to a potential systemic issue with vitros cov2tot lot 0380.An instrument issue cannot be ruled out as a contributor to the event, as no testing was undertaken to confirm the performance of the instrument.Additionally, the false reactive result was isolated to one instrument and additional qc results obtained from three different instruments were all acceptable.It is possible qc fluid mix up occurred, with the vitros cov2tot lot 0100 level 2 (reactive) fluid run in error instead of the non-reactive level 1 qc fluid, however, this could not be confirmed.Qc fluid material contamination cannot be ruled out as a contributor to the event.It was not determined if all testing conducted on (b)(6)2021 was from the same qc fluid bottle/aliquot.Acceptable results were obtained when fresh qc material was used as part of repeat testing on 29 march 2021.Email address for contact office is (b)(6).
 
Event Description
An ortho clinical diagnostics quality engineer (qe) reported a false reactive anti-sars-cov-2 total (cov2tot) result when a vitros cov2tot non-reactive quality control (qc) fluid was processed during internal post-expiry stability testing using vitros cov2tot lot 0380 in combination with a vitros eci immunodiagnostic system.Vitros cov2tot = 1.68 s/c (reactive) versus the expected result of non-reactive.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.The vitros cov2tot false reactive result was generated from a non-patient fluid, however the investigation cannot conclude that patient sample results would not be affected if the event were to recur undetected.There was no allegation of patient harm as a result of the event.This report corresponds to ortho clinical diagnostics inc.Complaint numbers (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-SARS-COV2 TOTAL REAGENT PACK
Type of Device
IN VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
laurie o'riordan
1295 southwest 29th avenue
pompano beach, FL 33069
9549709500
MDR Report Key11716790
MDR Text Key267279231
Report Number3007111389-2021-00053
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
Reporter Country CodeUK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 04/23/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/23/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date09/10/2021
Device Catalogue Number6199922
Device Lot Number0380
Was Device Available for Evaluation? Yes
Date Manufacturer Received03/25/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/11/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-